Related Experiment Video
Updated: Jun 17, 2025

Development of a Direct Pulp-capping Model for the Evaluation of Pulpal Wound Healing and Reparative Dentin Formation in Mice
Published on: January 12, 2017
Adrenaline in pulp capping treatment of reversible pulpitis
Si-Yun Yang1, Jin-Zhu Wang2, Hao Fan1
1Department of Stomatology, Anhui Jieshou People's Hospital, Fuyang 236500, Anhui Province, China.
Epinephrine (adrenaline) effectively treated reversible pulpitis with pulp capping, reducing pain and improving symptoms. It acts as a protective factor, unlike Streptococcus and Fusobacterium nucleatum, which are risk factors.
Area of Science:
- Dentistry
- Endodontics
- Oral Surgery
Background:
- The efficacy of epinephrine (adrenaline) in pulp capping for reversible pulpitis remains unclear.
- This study investigates the role of adrenaline in managing reversible pulpitis via pulp capping.
Purpose of the Study:
- To evaluate the therapeutic role of epinephrine in pulp capping for patients with reversible pulpitis.
- To compare the clinical outcomes and safety of adrenaline versus zinc oxide eugenol paste.
Main Methods:
- 100 patients with reversible pulpitis were divided into two groups: adrenaline (observation) and zinc oxide eugenol paste (control).
- Outcomes measured included 24-h postoperative pain, gingival healing time, clinical efficacy, and adverse reactions.
- Logistic regression analyzed factors influencing treatment success.
Main Results:
- The adrenaline group showed significantly lower 24-h postoperative pain and faster regression of gingival inflammation.
- A higher overall effective rate (94%) was observed in the adrenaline group compared to the control group (80%).
- Adrenaline was identified as a protective factor, while Streptococcus and Fusobacterium nucleatum were risk factors for treatment failure.
Conclusions:
- Adrenaline is a safe and effective agent for pulp capping in reversible pulpitis, improving pain and clinical outcomes.
- Adrenaline demonstrates protective effects, whereas anaerobic bacteria like Streptococcus and Fusobacterium nucleatum pose risks.
- Targeted interventions can enhance pulp capping treatment efficacy.
Related Concept Videos
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Drug Delivery: Enteral Route
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...

